Why Only 20% Of Benzinga Cannabis Capital Conference Attendees Invest In Cannabis Stocks
At the recent Benzinga Cannabis Capital Conference, Michael Berger, managing partner at Stonebridge Partners, shared valuable perspectives based on his transition from equity research to the cannabis market.
He emphasized the exceptional networking quality at the conference, noting that the blend of attendees, ranging from executives to investors, enriched understanding of market trends.
Investor Participation and Stock Performance
Berger revealed a surprising statistic during his discussion: a mere 20% of conference attendees were currently investing in cannabis despite substantial increases in cannabis stock values, almost doubling over the past year.
He attributed this low engagement to prior market downturns, which might have made investors wary. However, through his investment newsletter, …